Fortive’s first quarter results were driven by robust demand in both its Intelligent Operating Solutions and Advanced Healthcare Solutions segments, supported by product innovation and targeted commercial investments. Management attributed the company’s performance to strong order growth, particularly in the Fluke data center solutions and recurring revenue streams. CEO Olumide Soroye highlighted the success of new AI-enhanced products and noted that recurring revenue, including hardware-as-a-service, outpaced overall revenue growth. Despite performance above Wall Street expectations, the market reacted negatively, likely reflecting concerns about sustainability and external cost pressures, including tariffs.

Is now the time to buy FTV? Find out in our full research report (it’s free for active Edge members).

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Fortive’s Q1 Earnings Call

• Nigel Coe (Wolfe Research) asked about the impact of additional selling days on Q2 results, with CFO Mark D. Okerstrom explaining that Q2 and Q3 margins and EPS are expected to be similar to Q1 due to less benefit from selling days but with some FX tailwind.
• Deane Dray (RBC Capital Markets) inquired about Fluke’s data center opportunity and newer technologies, with CEO Olumide Soroye highlighting ongoing innovation, customer pull-through, and the enduring tailwind from data center build-outs and maintenance needs.
• Julian Mitchell (Barclays) pressed for details on order momentum and short-cycle businesses, and Soroye emphasized broad-based order growth and durable performance in both Fluke and healthcare consumables, with no signs of demand weakness.
• Andy Kaplowitz (Citigroup) asked about hospital capital spending trends in Advanced Healthcare Solutions, with Soroye noting sequential improvement and optimism as U.S. budget pressures ease and made-in-country initiatives in China and India gain traction.
• Scott Graham (Seaport Research Partners) questioned productivity targets and sustainability, receiving confirmation from Soroye that the targeted 50 to 100 basis points of annual adjusted EBITDA margin expansion is expected to be supported by ongoing productivity and reinvestment in growth.

Catalysts in Upcoming Quarters

In the coming quarters, key areas to watch include (1) the adoption and revenue contribution of AI-driven and data center-focused products, (2) the resolution of tariff impacts on gross margins and the effectiveness of cost containment measures, and (3) the pace and execution of bolt-on acquisitions under the company’s revamped M&A strategy. Progress in recurring revenue and further operational improvements will also be key indicators of management’s strategy execution.

Fortive currently trades at $60.43, down from $61.75 just before the earnings. At this price, is it a buy or sell? See for yourself in our full research report (it’s free).

The Best Stocks for High-Quality Investors

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum - both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks - FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.